发明名称 |
Methods of treating traveler's diarrhea and hepatic encephalopathy |
摘要 |
Treatment of traveler's diarrhea using in subjects having hepatic encephalopathy using gastrointestinal specific antibiotics is disclosed. One example of a gastrointestinal specific antibiotic is rifaximin. |
申请公布号 |
US8946252(B2) |
申请公布日期 |
2015.02.03 |
申请号 |
US201213654978 |
申请日期 |
2012.10.18 |
申请人 |
Salix Pharmaceuticals, Ltd |
发明人 |
Forbes William;Bortey Enoch |
分类号 |
A61K31/437;A61P1/12 |
主分类号 |
A61K31/437 |
代理机构 |
McCarter & English, LLP |
代理人 |
McCarter & English, LLP ;Sparks Jonathan M.;DeGrazia Michael J. |
主权项 |
1. A method of reducing the risk of overt hepatic encephalopathy (HE) recurrence in a subject comprising:
identifying a subject having Traveler's Diarrhea (TD) that also has hepatic insufficiency; determining if the subject's Child-Pugh score is Child-Pugh Class C or if the subject's model end stage liver disease (MELD) score is 25 or greater; and administering between 1000 and 1200 mg of rifaximin daily and cautiously to the subject if his or her Child-Pugh score is Child-Pugh Class C or if his or her MELD score is 25 or greater. |
地址 |
Raleigh NC US |